Medeon Biodesign, Inc. (TPEX:6499)
61.60
-0.30 (-0.48%)
Aug 19, 2026, 1:30 PM CST
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 6 billion as of August 19, 2026. Its market cap has decreased by -35.52% in one year.
Market Cap
6.00B
Enterprise Value
5.23B
Revenue
428.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.60
ChartMarket Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 6.00B, an increase of 4.01%. That is a compound annual growth rate of 0.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 6.00B | -31.16% |
| Dec 31, 2025 | 8.72B | 138.60% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Visco Vision | 12.63B |
| Vizionfocus | 11.62B |
| Bioteque | 7.93B |
| Pacific Hospital Supply | 5.60B |
| Formosa Optical Technology | 5.36B |
| St.Shine Optical | 4.76B |
| Bionime | 4.42B |
| SciVision Biotech | 3.71B |